#zepbound
10 stories
Sorority Rush Gets Ozempic Makeover
College women use weight-loss injections to compete in sorority rush.
Fox News · 2m
Eli Lilly Price Target Boost
Berenberg upgrades Eli Lilly to Buy with 20% upside potential.
Yahoo Finance · 1m
Eli Lilly Q2 2026 Revenue Surge
Lilly's Mounjaro revenue nearly doubled to $9.94 billion in Q2 2026, driving 48% revenue growth.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Lilly captures 70% of new Medicare GLP-1 patients
Eli Lilly CEO says 700,000 seniors started weight loss drugs after Medicare coverage launched in July, with Lilly drugs taking the majority.
CNBC · 1m
Eli Lilly's Tough Month: Bank Predicts 37% Gains
Citi forecasts 37% stock gains for Eli Lilly as selloff ends.
24/7 Wall St. · 1m
Eli Lilly's $1500 Target Surprises Wall Street
Eli Lilly's revenue growth outpaces stock price, with analysts missing a $1500 target by 2027
24/7 Wall St. · 1m
Nvidia vs. Eli Lilly: Which Stock Wins Next Decade?
Nvidia's AI infrastructure and Eli Lilly's GLP-1 drugs both surged, but which stock has the cleaner path to 10-year growth?
24/7 Wall St. · 1m
Noom promo codes save you cash on weight loss
Get discounts on psychology-based coaching, GLP-1 support, and AI-powered tracking.
WIRED · 1m
Eli Lilly's obesity bet hinges on September 30 data
A two-drug combo could justify Lilly's trillion-dollar valuation, but the mid-stage trial results will determine if it's a breakthrough or an expensive gamble.
24/7 Wall St. · 1m
Fasting on GLP-1 drugs: What you need to know for Yom Kippur
Millions take Ozempic and similar medications, adding a medical twist to religious fasts that require careful planning.
The Conversation · 2m